HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

With Democrat In White House, “More Aggressive” FDA Comes Into Focus

This article was originally published in The Rose Sheet

Executive Summary

Democratic control of the White House, Senate and House brings the potential of a "more aggressive" FDA into sharp focus

You may also be interested in...



Environmental Safety Regs For Cosmetic Chemicals On Council’s Radar In ‘09

The Personal Care Products Council is keeping an eye out for state and federal legislation aimed at providing "the next level" of chemicals safety by chronicling an ingredient's environmental effects

Environmental Safety Regs For Cosmetic Chemicals On Council’s Radar In ‘09

The Personal Care Products Council is keeping an eye out for state and federal legislation aimed at providing "the next level" of chemicals safety by chronicling an ingredient's environmental effects

FDA Head Von Eschenbach Resigning In January; Industry Awaits Successor

FDA Commissioner Andrew von Eschenbach will return to Texas upon resigning his post Jan. 20, closing out a bumpy tenure marked by some notable successes

Related Content

UsernamePublicRestriction

Register

RS015801

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel